The present invention provides compounds of formula (I): (Formula (I); wherein A, R1, R2, R3I, V, X, and Z are defined herein, which are potassium channel inhibitors. The invention further provides pharmaceutical compositions comprising the compounds of formula (I) and their use in therapy, in particular in treatment of diseases or conditions that are mediated by Kir3.1 and/or Kir3.4 or any heteromultimers thereof, or that require inhibition of Kir3.1 and/or Kir3.4 or any heteromultimers thereof.
本发明提供了式(I)的化合物:(式(I);其中A、R1、R2、R3I、V、X和Z在此处定义,它们是
钾通道
抑制剂。该发明还提供了包含式(I)化合物的药物组合物,以及它们在治疗中的使用,特别是在治疗由Kir3.1和/或Kir3.4或其异源多聚体介导的疾病或症状,或需要抑制Kir3.1和/或Kir3.4或其异源多聚体的情况。